Insights into the clinical development of regenerative medical products through a comparison of three cell-based products recently approved for limbal stem cell deficiency

Three regenerative medical products for limbal stem cell deficiency (LSCD), a rare and intractable ocular surface disease, have recently been approved in Japan. To our knowledge, this is the first time multiple stem-cell-based medical products have been approved for the same ocular disease. Developm...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The ocular surface 2023-07, Vol.29, p.220-225
Hauptverfasser:	Aketa, Naohiko, Kasai, Masaki, Noda, Shinichi, Asano, Junichi, Kunieda, Akiyoshi, Kawanishi, Shohei, Maruyama, Yoshiaki, Honda, Futaba
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical development Cultivated limbal epithelial transplantation Cultivated oral mucosal epithelial cell transplantation Limbal stem cell deficiency Ocular surface disease Regenerative medical products Symblepharon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!